MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
26
Beneficiaries
—
Total drug cost
$428
Distinct drugs
2
Brand share
53.8%
Top prescribed drugs
Ondansetron14 claims
Fluticasone Propionate12 claims
QUALITY · MIPS · 2024
Final MIPS score
90.9
Quality
69.7
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.67%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE